arrow
C

Chelsea Mayoh

children's cancer institute
H指数:33
被引数:3,932

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prior therapy defines mutation profiles in childhood cancer at relapse

既往治疗定义了儿童癌症复发时的突变谱

Nature
IF48.5
2026-07-220
OAAI
Precision-guided therapy in H3K27-altered diffuse midline glioma

H3K27-改变的弥漫性中线胶质瘤中的精准导向疗法

2026-05-190
OAAI
Combined inhibition of FACT and BET disrupts transcription to suppress tumor growth in mouse models of diffuse midline glioma

联合抑制FACT和BET破坏转录以抑制弥漫性中线胶质瘤小鼠模型的肿瘤生长

2026-01-140
PRE
CHROMATIN REMODELING WITH COMBINED FACT AND BET INHIBITION DISRUPTS ONCOGENIC TRANSCRIPTION IN DIFFUSE MIDLINE GLIOMA

联合FACT和BET抑制的染色质重塑破坏弥漫性中线胶质瘤中的致癌转录

2025-11-010
OAAI
P-glycoprotein as a chemotherapy resistance mechanism and biomarker of poor response in high-risk neuroblastoma
2025-11-010
OA
High-throughput 3D engineered paediatric tumour models for precision medicine

高通量3D工程化儿科肿瘤模型用于精准医学

2025-10-010
OAAI
The Super Enhancer-Driven Long Noncoding RNA PRKCQ-AS1 Promotes Neuroblastoma Tumorigenesis by Interacting With MSI2 Protein and Is Targetable by Small Molecule Compounds

超增强子驱动的长链非编码RNA PRKCQ-AS1通过与其SI2蛋白相互作用促进神经母细胞瘤肿瘤发生,且可被小分子化合物靶向。

2025-03-180
OAAI
Germline analysis of an international cohort of pediatric diffuse midline glioma patients

对国际队列儿童弥漫性中线胶质瘤患者的生殖系分析

2025-03-120
PRE
Polyamine depletion limits progression of acute leukaemia
2025-02-220
PRE
High-throughput in vitro drug screening and in vivo studies identify fenretinide as a brain-penetrant DMG therapeutic

高通量体外药物筛选和体内研究将fenretinide确定为一种能够穿透血脑屏障的DMG治疗药物。

2025-02-120
PRE
Copper chelation redirects neutrophil function to enhance anti-GD2 antibody therapy in neuroblastoma

铜螯合改变中性粒细胞功能以增强神经母细胞瘤的anti-GD2抗体治疗

2024-12-120
OAAI
The third generation AKR1C3-activated prodrug, ACHM-025, eradicates disease in preclinical models of aggressive T-cell acute lymphoblastic leukemia
2024-11-060
OAAI